Verus Financial Partners Inc. Grows Stake in Procter & Gamble Company (The) $PG

Verus Financial Partners Inc. grew its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 12.7% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,722 shares of the company’s stock after buying an additional 307 shares during the period. Verus Financial Partners Inc.’s holdings in Procter & Gamble were worth $429,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in PG. Kingstone Capital Partners Texas LLC increased its position in shares of Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after buying an additional 76,017,350 shares during the period. Northern Trust Corp grew its holdings in shares of Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock worth $5,051,930,000 after acquiring an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD raised its position in shares of Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after acquiring an additional 2,466,308 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in shares of Procter & Gamble by 3.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock valued at $2,966,252,000 after purchasing an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Procter & Gamble by 6.3% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock worth $2,947,146,000 after purchasing an additional 1,018,865 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. UBS Group set a $180.00 price objective on Procter & Gamble and gave the company a “buy” rating in a research report on Wednesday, July 30th. Evercore ISI reissued an “in-line” rating and set a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. BNP Paribas restated an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a report on Friday, August 15th. Barclays lowered their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a report on Wednesday. Finally, JPMorgan Chase & Co. restated a “neutral” rating and issued a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Eleven analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average target price of $173.11.

Procter & Gamble Trading Up 0.1%

Shares of NYSE PG opened at $152.19 on Friday. The firm’s 50 day moving average price is $155.51 and its 200-day moving average price is $160.06. Procter & Gamble Company has a 52-week low of $149.91 and a 52-week high of $180.43. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The company has a market cap of $356.20 billion, a PE ratio of 23.38, a P/E/G ratio of 4.01 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. During the same period in the previous year, the business earned $1.40 EPS. The firm’s revenue for the quarter was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities research analysts expect that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a $1.0568 dividend. This represents a $4.23 annualized dividend and a yield of 2.8%. The ex-dividend date was Friday, July 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 64.98%.

Insider Buying and Selling

In other news, CEO Ma. Fatima Francisco sold 9,100 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,431,157.00. Following the completion of the transaction, the chief executive officer directly owned 27,295 shares of the company’s stock, valued at $4,292,684.65. The trade was a 25.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Susan Street Whaley sold 1,000 shares of the stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $156.84, for a total transaction of $156,840.00. Following the transaction, the insider owned 28,436 shares in the company, valued at approximately $4,459,902.24. This trade represents a 3.40% decrease in their position. The disclosure for this sale can be found here. Insiders sold 120,181 shares of company stock worth $18,918,012 in the last three months. 0.20% of the stock is currently owned by company insiders.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.